Routine screening for HCC with ultrasound (US) and alpha fetoprotein (AFP) serum levels are recommended in patients with cirrhosis and high-risk patients without cirrhosis but with chronic HBV [2]. The gene discussed is AFP; the disease is hepatocellular carcinoma.